Community series in novel biomarkers for predicting response to cancer immunotherapy: volume II

被引：1
|
作者：
Peng, Keyong [1 ]
Pan, Jinghua [2 ]
机构：
[1] Jinan Univ, Affiliated Hosp 1, Med Off Panyu Compus, Guangzhou, Peoples R China
[2] Jinan Univ, Affiliated Hosp 1, Dept Gen Surg, Guangzhou, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词：
cancer immunotherapy; biomarker; immune check inhibitor; response; prognosis;
D O I：
10.3389/fimmu.2023.1328299
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges
    Cesano, Alessandra
    Cannarile, Michael A.
    Gnjatic, Sacha
    Gomes, Bruno
    Guinney, Justin
    Karanikas, Vaios
    Karkada, Mohan
    Kirkwood, John M.
    Kotlan, Beatrix
    Masucci, Giuseppe, V
    Meeusen, Els
    Monette, Anne
    Naing, Aung
    Thorsson, Vesteinn
    Tschernia, Nicholas
    Wang, Ena
    Wells, Daniel K.
    Wyant, Timothy L.
    Rutella, Sergio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [42] Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer
    Camidge, D. Ross
    Schenk, Erin L.
    CELL, 2020, 183 (02) : 303 - 304
  • [43] A novel integrated approach to predicting cancer immunotherapy efficacy
    Luo, Ruihan
    Chyr, Jacqueline
    Wen, Jianguo
    Wang, Yanfei
    Zhao, Weiling
    Zhou, Xiaobo
    ONCOGENE, 2023, 42 (23) : 1913 - 1925
  • [44] A novel integrated approach to predicting cancer immunotherapy efficacy
    Ruihan Luo
    Jacqueline Chyr
    Jianguo Wen
    Yanfei Wang
    Weiling Zhao
    Xiaobo Zhou
    Oncogene, 2023, 42 : 1913 - 1925
  • [45] Blood-based proteomic biomarkers for predicting response to immunotherapy in non-small cell lung cancer
    Shaked, Y.
    Kamer, I.
    Harel, M.
    Lahav, C.
    Jacob, E.
    Issler, E.
    Dicker, A. P.
    Bar, H.
    Sharon, O.
    Bar, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S849 - S849
  • [46] N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancer
    Bai, Zhihui
    Xia, Qianlin
    Xu, Wanli
    Wu, Zhirong
    He, Xiaomeng
    Zhang, Xin
    Wang, Zhefeng
    Luo, Mengting
    Sun, Huaqin
    Liu, Songmei
    Wang, Jin
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2025, 82 (01)
  • [47] MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer
    Xiong, Man
    Wang, Mingsen
    Yan, Youhong
    Chen, Xiaowu
    Guo, Wanwei
    Xu, Ming
    Guo, Shaoyan
    Wang, Yeyang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [48] MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer
    Xiong, Man
    Wang, Mingsen
    Yan, Youhong
    Chen, Xiaowu
    Guo, Wanwei
    Xu, Ming
    Guo, Shaoyan
    Wang, Yeyang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [49] The Multiple Potential Biomarkers for Predicting Immunotherapy Response-Finding the Needle in the Haystack
    Adam, Tamiem
    Becker, Therese M.
    Chua, Wei
    Bray, Victoria
    Roberts, Tara L.
    CANCERS, 2021, 13 (02) : 1 - 20
  • [50] Development of Circulating and Tissue Biomarkers Predicting Immune Phenotype and Response to Immunotherapy in NSCLC
    Henderson, B. D.
    Maguire, P.
    Keartland, S. I.
    Barr, M. P.
    Crulhas, B. P.
    Keating, G.
    Fitzmaurice, G. J.
    Gray, S.
    Nicholson, S.
    Finn, S. P.
    Gately, K. A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S197 - S198
12345